Charles A. Dinarello

Charles A. Dinarello is a distinguished Professor of Medicine and Immunology at the University of Colorado School of Medicine, and Professor of Experimental Medicine at Radboud University in the Netherlands. He is one of the world's foremost experts on cytokines, particularly Interleukin-1 and related molecules.

Dr. Dinarello's research has focused on the role of cytokines in inflammation and immune responses for decades. His work has been instrumental in understanding the mechanisms of inflammatory diseases and developing therapeutic approaches targeting cytokine pathways. He has made seminal contributions to the field of immunology, particularly in elucidating the biology of the interleukin-1 family of cytokines and their role in disease pathogenesis.

Dr. Dinarello's publication record demonstrates a consistent trajectory of groundbreaking research, with recent work expanding into neuroinflammation (particularly in Alzheimer's disease), cancer immunology, and the complex regulatory networks of inflammatory pathways. His research bridges basic science and clinical applications, with numerous discoveries leading directly to therapeutic approaches now used in clinical practice.

His numerous scientific awards include:

• Squibb Award (USA)
• Ernst Jung Prize in Medicine (Germany)
• Chirone Prize (Italian National Academy of Medicine)
• Carol Nachman Prize (Germany)
• Sheikh Hamdan bin Rashid al Maktoum Award (United Arab Emirates)
• Beering Prize (USA)
• Albany Prize in Medical Research (USA)
• Crafoord Prize of the Royal Swedish Academy of Sciences (Sweden)
• Paul Ehrlich Prize (Germany)
• Bonfils-Stanton Prize (USA)
• Novartis Prize in Clinical Immunology (Switzerland)
• Bonazinga Award (USA)

Dr. Dinarello has held significant leadership positions including President of the International Cytokine Society and Vice President of the American Society of Clinical Investigation. He serves on the Board of Governors of the Weizmann Institute and Ben Gurion University in Israel, reflecting his international scientific influence. His laboratories at both the University of Colorado and Radboud University continue to be at the forefront of cytokine research, investigating fundamental mechanisms and potential therapeutic applications.